Equites Radar

SOLS · Solstice Advanced Materials Inc

Specialty ChemicalsUnited StatesAnalyst view: Strong Buy

$61.65

+0.14% last session

End-of-day data · close of 2026-09-11

Neutral2 bullish · 2 bearish technical signals
Consensus: Buy (1.50 from 8 analysts)
To mean target: +30.4%

Market cap

$10B

Enterprise value

$11B

Trailing P/E

47.7

Forward P/E

18.2

Dividend yield

0.0%

Beta

Avg volume

3M

Employees

4K

Daily Change %

0.14%

5 Days Change

-0.74%

10 Days Change

-0.21%

30 Days Change

3.66%

60 Days Change

3.33%

Month to Day Change

2.48%

Year to Day Change

30.63%

Analyst Outlook

Consensus ratingBuy
Recommendation mean (1–5)1.50
Covering analysts8
Mean price target$80.25
Low price target$70.00
Upside to mean target+30.4%

Analyst estimates change daily — follow the shifts on the Estimate Trends page.

Technical Analysis

RSI (14)50.5
50-day MA$60.93
200-day MA$68.28
Price vs 50-day MA+1.2%
Price vs 200-day MA-9.7%
MACD histogram0.55
Volume vs 3-month avg0.3×
52w low $41.3052w high $88.48

Analyst sentiment over time — SOLS

Rec Mean (blue, left — higher = more bullish) vs. price targets (right).

Investment Bank Ratings as of 2026-09-03

Latest call per bank · past 12 months

Jefferies

Buy

$86.00

+39.7% vs price
▲ raised from $0.00Initiates · 2026-09-03

UBS

Buy

$80.00

+30.0% vs price
▲ raised from $78.00Maintains · 2026-07-31

RBC Capital

Outperform

$82.00

+33.2% vs price
▼ cut from $102Maintains · 2026-07-31

Recent rating actions

DateFirmActionRatingPrice target
2026-09-03JefferiesInitiatesBuy$0.00 $86.00
2026-07-31UBSMaintainsBuy$78.00 $80.00
2026-07-31RBC CapitalMaintainsOutperform$102 $82.00
2026-07-16BMO CapitalMaintainsOutperform$101 $90.00
2026-07-15MizuhoMaintainsNeutral$95.00 $70.00
2026-07-13UBSUpgradeNeutralBuy$88.00 $78.00
2026-07-09Truist SecuritiesUpgradeHoldBuy$90.00 $75.00
2026-07-01MizuhoMaintainsNeutral$85.00 $95.00

Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.

Signal Summary as of 2026-09-11

  • RSI (14): RSI is 51 — neutral momentum, neither overbought nor oversold.
  • Price vs 50-day MA: Trading 1.2% above the 50-day MA ($60.93).
  • Price vs 200-day MA: Trading 9.7% below the 200-day MA ($68.28).
  • MA cross: The 50-day MA sits below the 200-day MA (death-cross regime) — the longer-term trend points down.
  • MACD (12,26,9): MACD histogram is positive (+0.55) — short-term momentum is improving.
  • 52-week range: Price sits between the 52-week low ($41.30) and high ($88.48).

SOLS Price Chart

Loading chart for SOLS

Fundamentals

Revenue (TTM)$4.0B
EBITDA$1.0B
Free cash flow$0M
Operating cash flow$1.0B
Book value / share$9.98
Net Debt / EBITDA1.9
WACC1.0%
Revenue growth11.00%
Earnings growth23.00%

About Solstice Advanced Materials Inc

Solstice Advanced Materials, Inc. operates as a specialty chemicals and advanced materials company in the United States and internationally. It operates in two segments: Refrigerants & Applied Solutions (RAS), and Electronic & Specialty Materials (ESM). The RAS segment manufactures and sells low global warming potential (LGWP) refrigerants, blowing agents, solvents, and aerosol materials; and provides, aerosol propellants, cleaning solvents, pharmaceutical packaging materials, and alternative energy services under the Solstice, Genetron, and Aclar brands. The ESM segment offers electronic materials, fibers and laboratory life science chemicals for semiconductor, defense, pharmaceutical, and construction markets. This segment provides sputtering targets, lightweight high-strength fibers, and high-purity life science solutions under the Spectra, Fluka, and Hydranal brands. Solstice Advanced Materials, Inc. was incorporated in 2025 and is headquartered in Morris Plains, New Jersey.

More in Specialty Chemicals

Screen SOLS against the full market on the Radar →

Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.